OctoPlus N.V.
Industry
- Biotechnology
- Liposomes
- Large Molecule
- Pharmaceuticals
- Vaccines
- Drug Delivery
- Controlled Release
- Macromolecule
- Contract Research Organization-CRO
- Services
Latest on OctoPlus N.V.
Promethera Biosciences SA NV has appointed Henrik L. Luessen chief business officer (CBO), Nancy Veulemans vice president clinical & medical affairs and Decebal Bora vice president regul
Nathalie Moll, currently secretary general of the European Association for Bioindustries,has been appointed EFPIA's director general – effective April, 2017. Eric Cornut will continue to lead EFPI
PharmAsia News: In the last year or so we have seen heightened activity related to Indian site inspections by U.S. FDA. What are your thoughts? G.V. Prasad: It is part of the growing process as co
Darmstadt, Germany-headquartered Merck KGaA has named Boehringer Ingelheim's former head of biopharmaceuticals, Simon Sturge, head of its biosimilars unit – effective 1 March 2014. Mr Sturge will be b